Literature DB >> 9802010

Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties.

Theresa Wilson1, Geoffrey W de Lisle1, Jovita A Marcinkeviciene2, John S Blanchardand2, Desmond M Collins1.   

Abstract

Antisense RNA is a versatile tool for reducing gene expression. It was used to determine if ahpC, a gene that is involved in defence against oxidative stress and isoniazid (INH) resistance, is important for virulence of Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex. Antisense RNA constructs of ahpC were made using different strength promoters in front of a reversed coding sequence of ahpC. These constructs were electroporated into a virulent wild-type M. bovis strain and a moderately virulent INH-resistant M. bovis strain that was catalase/peroxidase-negative. Down-regulation of protein synthesis occurred and this was visualized by immunoblotting. All strains containing antisense RNA were markedly less virulent than their parent strains in guinea pigs. M. bovis with an up-regulated ahpC gene was more resistant to cumene hydroperoxide than its parent strain, which had a wild-type ahpC promoter. These results agree with a model of INH resistance in which overexpression of AhpC compensates in some INH-resistant strains for loss of catalase/peroxidase by maintaining the ability to defend against oxidative stress mediated through organic peroxides. In addition, normal expression of AhpC is crucial for maintaining the virulence of wild-type M. bovis, which has normal catalase/peroxidase levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802010     DOI: 10.1099/00221287-144-10-2687

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  36 in total

1.  Catalase-peroxidases of Legionella pneumophila: cloning of the katA gene and studies of KatA function.

Authors:  P Bandyopadhyay; H M Steinman
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Authors:  Rosilene Fressatti Cardoso; Robert C Cooksey; Glenn P Morlock; Patricia Barco; Leticia Cecon; Francisco Forestiero; Clarice Q F Leite; Daisy N Sato; Maria de Lourdes Shikama; Elsa M Mamizuka; Rosario D C Hirata; Mario H Hirata
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Comparative study of the roles of AhpC and KatE as respiratory antioxidants in Brucella abortus 2308.

Authors:  Kendra H Steele; John E Baumgartner; Michelle Wright Valderas; R Martin Roop
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

Review 5.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

6.  Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection.

Authors:  Y Ji; A Marra; M Rosenberg; G Woodnutt
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

7.  Regulated Expression Systems for Mycobacteria and Their Applications.

Authors:  Dirk Schnappinger; Sabine Ehrt
Journal:  Microbiol Spectr       Date:  2014

Review 8.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

9.  Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis.

Authors:  Deborah E Geiman; Deepak Kaushal; Chiew Ko; Sandeep Tyagi; Yukari C Manabe; Benjamin G Schroeder; Robert D Fleischmann; Norman E Morrison; Paul J Converse; Ping Chen; William R Bishai
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 10.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.